OUTCOME MEASUREMENT IN KIDNEY-DISEASE

被引：4

作者：

KAPLAN, RM

MEHTA, R

机构：

[1] University of California, San Diego, CA

来源：

BLOOD PURIFICATION | 1994年 / 12卷 / 01期

基金：

美国医疗保健研究与质量局;

关键词：

QUALITY OF WELL-BEING SCALE; QUALITY OF LIFE; COST EFFECTIVENESS; END-STAGE RENAL DISEASE;

D O I：

10.1159/000170141

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The effects of chronic kidney disease have been difficult to quantify using traditional measures of mortality and biological processes. New approaches to the quantification of outcomes in kidney disease are required. A wide variety of methods have become available and are now in use in some studies. Psychometric approaches, such as the Sickness Impact Profile and the Kidney Disease Questionnaire, have been shown to be responsive to change in some clinical studies. In order to estimate the cost-effectiveness of investments in kidney disease, decision theory approaches are required. We argue that these decision theory approaches should be given serious consideration for inclusion in clinical trials and in the US Renal Data System.

引用

页码：20 / 29

页数：10

共 25 条

[1]

Sanlorius N., A WHO method for the assessment of health-related quality of life (WHOQOL), Quality of Life Assessment, Key Issues for the 1990s, pp. 207-210, (1993)

[2]

Centers for Disease Control and Prevention, Workshop on Quality of Life/Health Status Surveillance, (1991)

[3]

Healthy People 2000: Department of Health and Human Services, (1991)

[4]

Schuttinga J.A., Quality of life assessment: Practice, problems and promise, (1993)

[5]

Kamlet M.S., A Framework for Cost- Utility Analysis of Government Health Care Programs, (1992)

[6]

Lavinsky N.G., Rettig R.A., Medicare End-Stage Renal Disease Program. A Report from the Institute of Medicine, N Engl J Med, 324, pp. 1143-1148, (1991)

[7]

Acciardo S.R., Moore LW, Burke L: Morbidity and mortality in hemodialysis patients, ASAIO Trans, 36, pp. M148-M151, (1990)

[8]

Collins A.J., Kjellstrand C.M., Shortening of the hemodialysis procedure and mortality in ‘healthy’ dialysis patients, ASAIO Trans, 36, pp. 146-158, (1990)

[9]

Schroeder S.A., Strategies for reducing medical costs by changing physician’s behavior, Int J Technol Health Care, 3, pp. 39-50, (1987)

[10]

Held P.J., Levin N.W., Bovbjerg R.R., Et al., Mortality and duration of hemodialysis treatment, JAMA, 265, pp. 871-875, (1990)

← 1 2 3 →